hong qin
Mayo Clinic Florida
Jacksonville, United States
Review Editor
Cancer Immunity and Immunotherapy
Mayo Clinic Florida
Jacksonville, United States
Review Editor
Cancer Immunity and Immunotherapy
The University of Texas at El Paso
El Paso, United States
Review Editor
Cancer Immunity and Immunotherapy
Peking University People's Hospital
Beijing, China
Review Editor
Cancer Immunity and Immunotherapy
Cancer Institute, Faculty of Medical Sciences, University College London
London, United Kingdom
Review Editor
Cancer Immunity and Immunotherapy
Discipline of Translation Medicine, Bristol Myers Squibb
New York, United States
Review Editor
Cancer Immunity and Immunotherapy
Commissariat Ă l'Energie Atomique et aux Energies Alternatives (CEA)
Paris, France
Review Editor
Cancer Immunity and Immunotherapy
Azenta Life Sciences
South Plainfield, United States
Review Editor
Cancer Immunity and Immunotherapy
School of Medicine, Emory University
Atlanta, United States
Review Editor
Cancer Immunity and Immunotherapy
Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ)
Heidelberg, Germany
Review Editor
Cancer Immunity and Immunotherapy
University of Windsor
Windsor, Canada
Review Editor
Cancer Immunity and Immunotherapy
University of Michigan
Ann Arbor, United States
Review Editor
Cancer Immunity and Immunotherapy
Helse Bergen HF, Haukeland University Hospital
Bergen, Norway
Review Editor
Cancer Immunity and Immunotherapy
Emory University
Atlanta, United States
Review Editor
Cancer Immunity and Immunotherapy
Mayo Clinic Arizona
Scottsdale, United States
Review Editor
Cancer Immunity and Immunotherapy
Department of Chemistry, College of Sciences, University of Hail
Hail, Saudi Arabia
Review Editor
Cancer Immunity and Immunotherapy
Oslo University Hospital
Oslo, Norway
Review Editor
Cancer Immunity and Immunotherapy